Who owns CITIUS PHARMACEUTICALS INC COM?
- Ticker: CTXR
- CUSIP Number: 17322u306
Tip: Access positions for across all investors
Analyze quarterly positions in Citius Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Citius Pharmaceuticals stock
Who bought or sold CITIUS PHARMACEUTICALS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 216k | $130k | -12% | Jun 2026 |
|
| Vanguard Capital Management | 197k | $119k | 18% | Jun 2026 |
|
| Miller Financial Services | 130k | $79k | 829% | Jun 2026 |
|
| Citadel Advisors | 125k | $76k | 329% | Jun 2026 |
|
| Jane Street | 123k | $74k | 165% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 78k | $47k | 0% | Jun 2026 |
|
| BlackRock | 70k | $42k | 0% | Jun 2026 |
|
| Northern Trust | 63k | $38k | 43% | Jun 2026 |
|
| XTX Topco | 59k | $36k | 178% | Jun 2026 |
|
| Asset Advisory Group | 59k | $36k | 0% | Jun 2026 |
|
| BostonPremier Wealth | 28k | $17k | 100% | Jun 2026 |
|
| UBS Group | 26k | $16k | -52% | Jun 2026 |
|
| LPL Financial | 25k | $15k | 2% | Jun 2026 |
|
| State Street Corporation | 23k | $21k | 0% | Mar 2026 |
|
| Virtu Financial | 21k | $13k | 100% | Jun 2026 |
|
| Arkadios Wealth Advisors | 20k | $12k | 0% | Jun 2026 |
|
| Two Sigma Investments | 18k | $11k | 33% | Jun 2026 |
|
| Sanctuary Advisors | 12k | $7.1k | 100% | Jun 2026 |
|
| Susquehanna International | 12k | $7.1k | -68% | Jun 2026 |
|
| R Squared | 11k | $6.7k | 100% | Jun 2026 |
|
| Two Sigma Securities | 10k | $6.0k | 100% | Jun 2026 |
|
| SBI Securities | 9.5k | $5.8k | 46% | Jun 2026 |
|
| Citigroup | 5.2k | $4.7k | 100% | Mar 2026 |
|
| Chelsea Counsel | 4.6k | $2.8k | 0% | Jun 2026 |
|
| Quent Capital | 4.2k | $2.6k | -1% | Jun 2026 |
|
| IFP Advisors | 4.2k | $2.5k | -41% | Jun 2026 |
|
| Tower Research Capital | 2.7k | $1.6k | -2% | Jun 2026 |
|
| Advisor Group Holdings | 2.6k | $1.5k | -6% | Jun 2026 |
|
| Group One Trading | 1.6k | $938.044800 | 100% | Jun 2026 |
|
| Morgan Stanley | 1.4k | $1.2k | -33% | Mar 2026 |
|
| Simplex Trading | 1.3k | $759.000800 | 100% | Jun 2026 |
|
| Barclays | 1.1k | $662.970400 | 100% | Jun 2026 |
|
| Wells Fargo & Company | 1.0k | $605.000000 | 100% | Jun 2026 |
|
| Luminist Capital | 435.00 | $263.001000 | 100% | Jun 2026 |
|
| Assetmark | 372.00 | $224.985600 | 0% | Jun 2026 |
|
| Princeton Global Asset Management | 160.00 | $96.992000 | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 120.00 | $69.000000 | 100% | Jun 2026 |
|
| Smallwood Wealth Investment Management | 120.00 | $72.000000 | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 107.00 | $65.002500 | 0% | Jun 2026 |
|
| SRS Capital Advisors | 84.00 | $50.996400 | 100% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 80.00 | $48.000000 | 0% | Jun 2026 |
|
| Fairscale Capital | 42.00 | $24.998400 | 0% | Jun 2026 |
|
| Bogart Wealth | 4.00 | $2.000000 | 0% | Jun 2026 |
|
Who sold out of Citius Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hrt Financial | Mar 2026 | 60k | $54k |
| Curio Wealth | Mar 2026 | 2.0k | $1.8k |
| Vanguard Global Advisers | Mar 2026 | 1.8k | $1.6k |
| Ameritas Advisory Services | Mar 2026 | 1.0k | $900.000000 |
| Goss Wealth Management | Mar 2026 | 400.00 | $360.000000 |
| Murphy & Mullick Capital Management Corp | Mar 2026 | 160.00 | $144.000000 |
| Northwestern Mutual Wealth Management Company | Mar 2026 | 8.00 | $8.000000 |